GSK J2

CAS : 1394854-52-4

Ref. 3D-UFC85452

Informations sur le produit

• Nom: GSK J2
• Marque: Biosynth
• Description: GSK J2 is a substance that inhibits the activity of histone methyltransferase enzymes. This drug has been shown to inhibit tumor growth and induce apoptosis in cancer cells. GSK J2 also increases insulin sensitivity, which may be due to its ability to suppress the production of Th17 cells. GSK J2 has been shown to improve insulin sensitivity in patients with type 2 diabetes. GSK J2 is an inhibitor of Hdac, a class of enzymes that regulate epigenetic gene expression. It has been shown to inhibit the growth factor-induced phosphorylation and activation of Akt/mTORC1 signaling pathway, which leads to decreased cell proliferation and increased apoptosis in mammalian cells.

Propriétés chimiques

• Masse moléculaire: 389.45 g/mol
• Formule: C₂₂H₂₃N₅O₂
• Degré de pureté: Min. 95%